Skip to main content

Nebraska

CANNABIS DISPENSARY REGULATIONS FOR NEBRASKA

Nebraska legalized medical cannabis through two voter-approved ballot initiatives in November 2024. The state is now developing a regulated medical cannabis market under the oversight of the Nebraska Medical Cannabis Commission.

Although medical cannabis is legal for qualifying patients, Nebraska’s commercial program is not yet fully operational. Cultivation and manufacturing licensing have begun, but dispensary applications have not opened and there are currently no licensed medical cannabis dispensaries serving patients.

Recreational cannabis remains illegal.

Medical Cannabis Commission and Regulatory Framework

Initiative Measure 438 established the Nebraska Medical Cannabis Commission and directed it to regulate the possession, manufacture, distribution, delivery, and dispensing of cannabis for medical purposes.

Nebraska’s first permanent medical cannabis regulations completed the required approval process in 2026. Attorney General Mike Hilgers approved the regulations on June 30, 2026, and Governor Jim Pillen approved them on July 1, 2026.

The Commission voted to advance additional proposed amendments and a new fee schedule in August 2026. Those amendments are not yet effective and must complete the state’s formal rulemaking process.

Until new regulations become effective, the Commission continues operating under its current licensing and renewal structure, including six-month license renewals.

Cannabis Business License Categories

Nebraska’s developing regulatory framework provides for several types of registered cannabis establishments, including:

  • Cultivators
  • Manufacturers
  • Testing facilities
  • Transporters
  • Dispensaries

Each license authorizes a specific part of the medical cannabis supply chain. A business may not cultivate, manufacture, transport, test, or dispense medical cannabis without the appropriate Commission-issued authorization.

Licensing is being introduced in stages rather than through one application window.

Current Licensing Status

The Commission accepted its initial cultivator applications from September 4 through September 23, 2025. That application period is closed, and the state has issued its first cultivation licenses.

The manufacturer application window opened in 2026 and closed on August 17, 2026.

According to the Commission’s current application information, application periods for transporter and dispensary licenses have not yet opened and remain dependent on additional program development and legislative action.

Because no dispensary application period has opened, Nebraska does not yet have an operational network of licensed medical cannabis retailers.

Businesses interested in entering the market should monitor the Commission’s website, proposed regulations, public meetings, and future application announcements. Proposed licensing fees are not effective until they complete rulemaking and receive all required approvals.

Patient and Caregiver Protections

Initiative Measure 437 created the Nebraska Medical Cannabis Patient Protection Act.

Under the law, a qualified patient with a valid written recommendation from an authorized healthcare practitioner may use, possess, and acquire up to five ounces of cannabis for medical purposes.

Authorized healthcare practitioners include:

  • Physicians
  • Osteopathic physicians
  • Physician assistants
  • Nurse practitioners

A written recommendation must state that, in the practitioner’s professional judgment, the potential benefits of cannabis outweigh its potential harms for treating or alleviating the patient’s medical condition, symptoms, or treatment side effects.

Recommendations are generally valid for two years unless the practitioner specifies a shorter period.

Patients younger than 18 may qualify with a written recommendation and permission from a parent or legal guardian. The law also permits qualified patients to designate caregivers under defined circumstances.

These protections do not create a general right to possess cannabis recreationally or purchase cannabis from an unlicensed seller.

Medical Cannabis Purchasing Rules

Once licensed dispensaries begin operating, sales will be restricted to qualified patients and authorized caregivers.

Under the current regulations, a dispensary must receive a valid written recommendation and written order electronically from an enrolled healthcare practitioner. The dispensary must also verify the identity of the patient or caregiver using approved identification.

A dispensary may not provide a patient with:

  • More than five ounces of medical cannabis
  • More than the quantity authorized by the written order
  • More than a 30-day supply
  • More than five grams of total THC during a 90-day period
  • A product containing more than 40 milligrams of THC per dose

A dispensary may not refill the same written order. The current rules also prohibit dispensaries from delivering medical cannabis directly to patients or caregivers.

Approved and Prohibited Products

Nebraska’s current medical cannabis regulations authorize a limited range of product forms.

Permitted products include:

  • Oral tablets
  • Capsules
  • Tinctures
  • Gels and oils
  • Creams and other topical preparations
  • Suppositories
  • Transdermal patches
  • Nasal sprays
  • Liquids or oils administered through a nebulizer or inhaler

The rules prohibit dispensaries from selling:

  • Raw cannabis flower or other raw plant material
  • Products intended for smoking or combustion
  • Vaping products
  • Cannabis-infused foods or beverages
  • Products containing artificial or natural flavoring or coloring
  • Products containing synthetic cannabinoids
  • Products exceeding 60 percent total THC
  • Products containing more than 40 milligrams of THC per dose

These restrictions make Nebraska’s developing program considerably more limited than the medical cannabis markets operating in many other states.

Testing, Packaging, and Operational Compliance

Licensed cannabis businesses must comply with detailed requirements governing security, inventory management, testing, packaging, transportation, and recordkeeping.

Medical cannabis must undergo independent laboratory testing for cannabinoid content and potential contaminants. Required testing includes potency, pesticides, heavy metals, residual solvents, microorganisms, mycotoxins, and other adulterants.

Patient products must be sold in tamper-evident and child-resistant packaging. Labels must provide required product, potency, ingredient, batch, manufacturer, patient, practitioner, and warning information.

Dispensaries must retain required transaction and patient documentation for at least seven years. Promotional giveaways and free cannabis products are prohibited.

No Recreational Sales or Home Cultivation

Nebraska has not legalized adult-use cannabis. Recreational dispensaries, commercial recreational sales, and cannabis delivery services remain prohibited.

The medical cannabis initiatives do not establish a general right for patients or adults to cultivate cannabis at home. Cultivation outside the licensed commercial framework remains illegal.

Possession that does not qualify for protection under the Nebraska Medical Cannabis Patient Protection Act remains subject to the state’s controlled-substance laws.

For a first offense, possession of one ounce or less is generally treated as an infraction carrying a $300 fine and possible drug-education requirements. Repeated offenses or possession of larger amounts may result in misdemeanor or felony penalties.

Hemp and Hemp-Derived Products

Nebraska permits the cultivation of federally compliant hemp. Beginning January 1, 2025, hemp producers in Nebraska have been required to obtain licensing through the USDA or an authorized tribal program rather than a state-administered cultivation program.

Additional information is available through the Nebraska Department of Agriculture’s hemp page.

Businesses should not assume that every product marketed as hemp is legal in Nebraska. State authorities have taken aggressive enforcement action against mislabeled, synthetic, intoxicating, and noncompliant THC products.

In March 2025, the Nebraska Attorney General announced an expanded Delta-8 and intoxicating-hemp enforcement initiative, including cease-and-desist letters and potential consumer-protection litigation against retailers.

CBD and hemp businesses should carefully review product composition, testing results, labeling, marketing claims, federal requirements, and Nebraska law before distributing products in the state.

Banking and Payment Considerations

Nebraska’s medical cannabis program remains in its earliest commercial stages. Licensed cannabis businesses will likely face enhanced banking, underwriting, reporting, and transaction-monitoring requirements because cannabis remains federally regulated.

Hemp and CBD businesses may also face payment-processing challenges when selling products containing cannabinoids, particularly when legality, formulation, labeling, or laboratory documentation is unclear.

PayRio works with eligible cannabis, hemp, and CBD businesses to evaluate payment solutions appropriate for their products, licenses, business models, and regulatory environments.

Learn more about PayRio’s cannabis payment solutions or contact our team to discuss your business.

Payment availability is subject to licensing, product review, provider requirements, and completed underwriting. Approval and uninterrupted processing cannot be guaranteed.

CANNABIS LEGALIZATION HISTORY IN NEBRASKA

Nebraska has historically maintained strict cannabis prohibition. Earlier attempts to establish a medical cannabis program through legislation and ballot initiatives repeatedly failed because of procedural, legal, and political obstacles.

In 2020, a proposed medical cannabis constitutional amendment qualified for the ballot but was removed following a Nebraska Supreme Court ruling that it violated the state’s single-subject requirement.

Advocates pursued another initiative campaign in 2022 but did not collect enough valid signatures to qualify.

In November 2024, Nebraska voters approved two separate medical cannabis measures:

  • Initiative Measure 437 established protections for qualified patients and caregivers
  • Initiative Measure 438 created the Nebraska Medical Cannabis Commission and a framework for regulated medical cannabis businesses

The measures faced a legal challenge alleging that petition irregularities left them without enough valid signatures to appear on the ballot.

On September 4, 2026, the Nebraska Supreme Court affirmed the lower court’s decision, rejected the attempt to invalidate the petitions, and left both voter-approved medical cannabis laws in effect.

Nebraska’s first permanent business regulations took effect in July 2026. The Commission continues to develop licensing, fees, enforcement procedures, and the remaining stages of the regulated supply chain.

CANNABIS LEGALIZATION STATUS IN NEBRASKA

Current Status: Medical cannabis is legal, but regulated dispensary sales have not started

Nebraska law currently allows:

  • Qualified patients to possess and use up to five ounces of cannabis with a valid written recommendation
  • Authorized caregivers to assist qualified patients
  • State-regulated medical cannabis cultivation and manufacturing
  • The future licensing of testing facilities, transporters, and dispensaries
  • Federally compliant hemp production under USDA or authorized tribal licensing

Nebraska law does not currently allow:

  • Recreational cannabis sales
  • Adult-use dispensaries
  • General home cultivation
  • Unlicensed medical cannabis sales
  • Smoking, vaping, raw flower, or cannabis-infused foods within the regulated medical program

Nebraska’s medical cannabis program is legally established but remains under development. Patients do not yet have access to licensed in-state dispensaries, and businesses must wait for the applicable license category and application period before operating.

LAST UPDATED 9/4/2026 – Laws and regulations can change frequently, so please keep this in mind.